⚠️FOR RESEARCH PURPOSES ONLY
ResearchPeptide

SLU-PP-332

Published Research

PubMed-indexed studies for SLU-PP-332

Research

A Synthetic ERR Agonist Alleviates Metabolic Syndrome.

The Journal of pharmacology and experimental therapeutics 2024
View on PubMed →
Research

Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.

ACS chemical biology 2023
View on PubMed →
Research

An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity.

The Journal of pharmacology and experimental therapeutics 2026
View on PubMed →
Research

In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential.

Rapid communications in mass spectrometry : RCM 2026
View on PubMed →
Research

Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling.

International journal of biological macromolecules 2026
View on PubMed →

Research-Grade SLU-PP-332

⚠️ For laboratory research only. Not for human use.